Attached files
| file | filename |
|---|---|
| 10-Q - VCYT 10Q Q2 2017 - VERACYTE, INC. | vcyt-06302017xq210q.htm |
| EX-32.1 - VCYT 10Q Q2 2017 EXHIBIT 32.1 - VERACYTE, INC. | vcyt-06302017xex321.htm |
| EX-31.2 - VCYT 10Q Q2 2017 EXHIBIT 31.2 - VERACYTE, INC. | vcyt-06302017xex312.htm |
| EX-31.1 - VCYT 10Q Q2 2017 EXHIBIT 31.1 - VERACYTE, INC. | vcyt-06302017xex311.htm |
| EX-10.1 - VCYT 10Q Q2 2017 EXHIBIT 10.1 - VERACYTE, INC. | vcyt-06302017xex101.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Veracyte, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: | July 31, 2017 | |
/s/ Keith S. Kennedy | ||
Keith S. Kennedy | ||
Chief Financial Officer | ||
(Principal Financial and Accounting Officer) | ||
1